Patents by Inventor NEW YORK BLOOD CENTER, INC.

NEW YORK BLOOD CENTER, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOLATION AND CULTURE OF ERYTHROID PROGENITOR CELLS
    Publication number: 20130209431
    Abstract: Disclosed herein are methods of isolating erythroid progenitor cells from a source of human hematopoietic cells and methods of culturing the isolated erythroid progenitor cells in vitro to produce clinically relevant quantities of erythrocytes.
    Type: Application
    Filed: February 13, 2013
    Publication date: August 15, 2013
    Applicant: NEW YORK BLOOD CENTER, INC.
    Inventor: NEW YORK BLOOD CENTER, INC.
  • SYSTEMS AND METHODS FOR DETERMINING ANTIBODY-MEDIATED RISK INDEX
    Publication number: 20130203090
    Abstract: Disclosed herein are systems and methods for assessing the risk of risk of hemolytic disease of the fetus or neonate, neonatal alloimmune thrombocytopenic purpura, or transfusion-associated lung injury in a patient or transfusion recipient.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 8, 2013
    Applicant: NEW YORK BLOOD CENTER, INC.
    Inventor: NEW YORK BLOOD CENTER, INC.